V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20043313 | 20086235 | 1.59 | 97 | Palliative (P) | 2017-09-08 | 2017-09-08 | FEC + DOCETAXEL | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101466316 |
| 20043315 | 20086236 | 1.55 | null | Palliative (P) | 2016-05-20 | 2016-05-20 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 02 | N | CAPECITABINE + LOMUSTINE | 100813493 |
| 20043392 | 20086238 | 1.71 | 95.5 | null | 2018-02-06 | 2018-02-13 | CAPECITABINE + CARBOPLATIN + Trastuzumab | 01 | null | CAPECITABINE + CETUXIMAB + IRINOTECAN | 100030030 |
| 20043417 | 20086239 | 1.6 | 41.9 | null | 2018-03-23 | 2018-03-30 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 01 | N | VENETOCLAX | 100539386 |
| 20043437 | 20086240 | 1.66 | 98.8 | null | 2018-04-12 | 2018-04-15 | CHOP R - 21 days | 01 | N | LENALIDOMIDE | 101424156 |
| 20043512 | 20086241 | 1.6 | 71.5 | Palliative (P) | 2022-02-17 | 2022-03-02 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | Y | CAP + RT | 100874935 |
| 20043523 | 20086242 | 0 | 0 | Palliative (P) | 2018-04-14 | 2018-05-10 | Doxorubin 50mg/m2 | 02 | null | NAB-PACLITAXEL | 100109627 |
| 20043527 | 20086243 | 1.68 | 67.2 | null | 2018-06-25 | 2018-07-12 | Raltitrexed | 02 | N | PEMBROLIZUMAB | 101675976 |
| 20043634 | 20086244 | 1.72 | 0 | 03 | 2021-03-18 | 2021-03-18 | CHLVPP | 01 | N | PHITT C CARBOPLATIN/DOXORUBICIN | 100738691 |
| 20043728 | 20086245 | 1.78 | 53.6 | 03 | 2017-12-24 | 2017-12-27 | Capecitabine + Streptozocin | 02 | Y | THALIDOMIDE | 101511802 |
| 20043748 | 20086246 | 1.71 | 75.6 | Palliative (P) | 2017-02-25 | 2017-03-17 | MITOMYCIN | 02 | N | ECARBOX | 101628912 |
| 20043864 | 20086247 | 1.59 | 74.4 | Palliative (P) | 2018-05-13 | 2018-06-09 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 01 | N | RALTITREXED | 101186934 |
| 20043869 | 20086248 | 1.53 | 48.85 | null | 2018-04-22 | 2018-04-23 | INTERAACT trial | 01 | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 100930574 |
| 20043899 | 20086249 | 1.72 | 68 | Palliative (P) | 2020-05-30 | 2020-05-31 | Bortezomib + CYCLOPHOSPHAMIDE | 01 | N | ANAGRELIDE | 101704983 |
| 20043962 | 20086250 | 1.6 | 62 | Adjuvant (A) | 2020-10-13 | 2020-10-19 | Cisplatin + Docetaxel +Fluorouracil | 01 | null | CARBOPLATIN + VINORELBINE | 101013587 |
| 20044010 | 20086251 | 1.66 | 72 | Palliative (P) | 2019-10-28 | 2019-11-15 | IBRUTINIB | 02 | N | NAB-PACLITAXEL | 100589992 |
| 20044025 | 20086252 | null | 64.3 | 03 | 2020-07-01 | 2020-07-15 | Atezolizumab | 02 | null | OXALIPLATIN + MDG + PANITUMUMAB | 100452392 |
| 20044110 | 20086253 | null | 72.1 | Palliative (P) | null | 2019-02-20 | Cytarabine Low Dose | null | null | EVEROLIMUS | 100133455 |
| 20044187 | 20086255 | 1.63 | 127.2 | Palliative (P) | 2017-06-26 | 2017-06-28 | DABRAFENIB + TRAMETINIB | 02 | null | LETROZOLE + PALBOCICLIB | 101260345 |
| 20044188 | 20086256 | 1.66 | 102 | 03 | 2016-10-08 | 2016-10-15 | CISPLATIN + FLUOROURACIL + RT | 02 | N | FOXTROT TRIAL | 101292906 |
| 20044197 | 20086257 | 1.78 | 72.2 | Palliative (P) | 2019-10-10 | 2019-10-10 | GemCarbo Days 1+8 | 02 | N | PEMBROLIZUMAB | 100824209 |
| 20044219 | 20086260 | 1.72 | 56 | null | 2018-11-06 | 2018-11-06 | Hydroxycarbamide | 02 | N | ARISTOTLE TRIAL | 100566298 |
| 20044263 | 20086261 | null | null | Adjuvant (A) | 2018-05-09 | 2018-05-17 | Carboplatin + Pembrolizumab + Pemetrexed | 01 | N | FOXTROT TRIAL | 100292654 |
| 20044307 | 20086262 | 1.84 | 69.8 | Palliative (P) | 2018-12-30 | 2019-01-17 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | CARBOPLATIN + FLUOROURACIL | 100270532 |
| 20044308 | 20086263 | 1.56 | 67.2 | Palliative (P) | 2020-01-23 | 2020-02-06 | Eribulin | 02 | N | FOXTROT TRIAL | 101585063 |
| 20044313 | 20086264 | 1.58 | 86.7 | Palliative (P) | null | 2018-06-23 | ANAGRELIDE | null | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100288589 |
| 20044317 | 20086265 | 1.69 | 51.3 | Palliative (P) | 2016-11-11 | 2016-11-11 | CETUXIMAB + RT | 02 | N | HYDROXYCARBAMIDE | 100587040 |
| 20044319 | 20086266 | 1.62 | 77 | null | null | 2021-02-18 | Bevacizumab + Cape + Oxali 21day | null | N | RALTITREXED | 100619987 |
| 20044335 | 20086267 | null | 71.4 | null | 2017-10-04 | 2017-10-04 | Cisplatin + Fluorouracil + RT 5day | 02 | N | ACTICCA-1 TRIAL | 101756136 |
| 20044345 | 20086269 | 1.76 | 74 | 03 | 2017-08-10 | 2017-08-31 | EC | 02 | N | CISPLATIN + TEYSUNO | 100031999 |
| 20044369 | 20086270 | 1.69 | 78 | Neo-adjuvant (N) | 2016-07-31 | 2016-08-04 | TEMOZOLOMIDE | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100045832 |
| 20044382 | 20086271 | 1.65 | 75.5 | 03 | 2018-03-06 | 2018-03-06 | Busulfan Oral | 2 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101797508 |
| 20044414 | 20086272 | 1.6 | 70 | Palliative (P) | null | 2018-06-18 | CAP + RT | 02 | N | AML19 TRIAL | 100097485 |
| 20044433 | 20086273 | 1.75 | 76.2 | 03 | 2017-07-01 | 2017-07-01 | Hydroxycarbamide | 01 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101002375 |
| 20044450 | 20086274 | 1.57 | null | Adjuvant (A) | 2017-11-22 | 2017-11-23 | PACLITAXEL | 01 | N | OXALIPLATIN | 100637474 |
| 20044460 | 20086275 | 1.73 | 101 | Palliative (P) | 2018-04-18 | 2018-04-19 | ECarboX | N | N | CARBOPLATIN + FLUOROURACIL | 101297449 |
| 20044552 | 20086277 | 1.72 | 55 | null | 2020-06-08 | 2020-06-26 | Fluorouracil + Folinic + RT Bossett | 02 | N | FLUOROURACIL + RT | 100304799 |
| 20044569 | 20086278 | 1.47 | 123.4 | null | 2018-12-10 | 2018-12-15 | CAPECITABINE + OXALIPLATIN + Trastuzumab | N | N | OXALIPLATIN + MDG + PANITUMUMAB | 100854197 |
| 20044645 | 20086279 | null | 7.1 | 03 | 2020-03-04 | 2020-03-04 | CAP + RT | 02 | N | PLATO TRIAL | 100964699 |
| 20044658 | 20086280 | 1.78 | 76 | Palliative (P) | 2017-02-27 | 2017-03-05 | MCX | 02 | Y | DOXORUBICIN | 101001659 |
| 20044715 | 20086281 | 1.57 | 75.9 | Palliative (P) | 2020-01-04 | 2020-01-25 | Paclitaxel albumin (Abraxane) 7 day | 02 | N | CARBO + FLUOROURACIL | 101479609 |
| 20044764 | 20086284 | 1.71 | 101.8 | 03 | 2019-11-17 | 2019-11-20 | PHITT C Carboplatin/Doxorubicin | N | N | EPIRUBICIN | 101730728 |
| 20044807 | 20086285 | 1.71 | 73.1 | Palliative (P) | 2018-11-29 | 2018-12-01 | FCarboSt | 02 | null | CHOP R | 100467185 |
| 20044812 | 20086286 | 1.78 | 70 | 03 | 2019-05-21 | 2019-06-10 | ANAGRELIDE | 02 | N | CISPLATIN + VINORELBINE | 100576216 |
| 20044842 | 20086287 | 1.7 | 56.4 | Palliative (P) | 2017-03-16 | 2017-03-16 | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 02 | N | NAB-PACLITAXEL | 100098706 |
| 20044878 | 20086288 | 1.46 | 68.8 | Adjuvant (A) | 2017-11-07 | 2017-11-08 | BALLAD Trial | 02 | N | RALTITREXED | 101281860 |
| 20044921 | 20086289 | 1.77 | 45 | 03 | 2017-09-30 | 2017-10-22 | CISPLATIN + TEYSUNO | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 101319700 |
| 20044945 | 20086291 | 1.56 | 80.95 | 03 | 2019-10-05 | 2019-10-09 | CAPECITABINE + LOMUSTINE | Y | N | PACLITAXEL | 101680378 |
| 20045135 | 20086294 | 1.58 | 62.1 | Adjuvant (A) | 2016-11-14 | 2016-12-05 | Docetaxel 75mg/m2 (21 day) | 02 | N | PENTOSTATIN | 101003096 |
| 20045208 | 20086296 | 1.67 | 120.9 | Palliative (P) | null | 2017-01-30 | GEMCARBO | null | N | GO2 TRIAL | 100723360 |